The aim of the present study was to investigate digital PD-L1 quantification versus physician PD-L1 quantification in pre-treatment tumor tissue of melanoma patients as potential predictors of therapy outcome of a PD-1-based ICB. The gene discussed is CD274; the disease is neoplasm.